Press release
Uncovering the Global Chronic Cough Market: Industry Analysis, Unleashing Future Demand and Forecast till 2032 || Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032The Business Research Company's Chronic Cough Global Market Report 2023 identifies the rise in the prevalence of cough is the major driver for the chronic cough market's growth in the forecast period. Cough refers to a reflex action that, frequently in response to irritation, mucus, or foreign objects, helps clear the airways by ejecting air forcefully from the lungs. A persistent cough that lasts for at least eight weeks is considered chronic. Therefore, when the incidence of cough rises, so do the cases of chronic cough. For instance, in March 2022, according to the Florida Health, a US-based Department of Healthcare, in the US total of 2,390 cases of whooping cough were found in 2020, and 80 patients were found in 2021, for incidences of 41.0 and 1.4 per 100,000 years, respectively. There were 28 pertussis cases recorded in 2023 among 13 countries.
The global chronic cough market is expected to grow from $6.88 billion in 2022 to $7.50 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chronic cough market is expected to reach $10.43 billion in 2027 at a CAGR of 8.6%.
Download Free Sample Of Chronic Cough Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp
Major competitors in the chronic cough market are Tris Pharma Inc.; Pfizer Inc.; Johnson & Johnson Co; Bayer AG; Novartis AG; Sanofi SA; Bristol-Myers Squibb Company; AstraZeneca plc; Glaxo SmithKline Plc; Merck KGaA; Reckitt Benckiser Group plc; Glenmark Pharmaceuticals Ltd; Teva Pharmaceutical Industries Ltd.; Mylan NV.
A key trend in the chronic cough market includes product innovations. Major companies operating in the chronic cough market are concentrating on creating innovative products to strengthen their position in the market. For instance, in October 2020, GSK Consumer Healthcare, a UK-based pharmaceutical and biotechnology company, launched Robitussin Naturals, a drug-free product that relieves occasional long-term cough. Robitussin users and proponents of natural wellness products are made with natural components to give people confidence in their solutions to treat spasmodic coughs.
Read More On The Global Chronic Cough Market Report Here:
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report
The chronic cough market is segmented -
1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes
2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route of Administrations
3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the chronic cough market.
The Business Research Company's "Global Chronic Cough Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Chronic Cough Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12109
The Table Of Content For The Chronic Cough Market Include:
1. Executive Summary
2. Chronic Cough Market Characteristics
3. Chronic Cough Market Trends And Strategies
4. Chronic Cough Market - Macro Economic Scenario
5. Chronic Cough Market Size And Growth
……………
27. Chronic Cough Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Chronic Cough Market
29. Chronic Cough Market Future Outlook And Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uncovering the Global Chronic Cough Market: Industry Analysis, Unleashing Future Demand and Forecast till 2032 || Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG here
News-ID: 3225528 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cough
Dog's Cough Intensifies Due to Temperature Difference, Trusted Dog Cough Medicin …
Image: https://www.getnews.info/uploads/e50cc9d317e270f5e3e669a0339f0b84.jpg
During periods of significant temperature fluctuations, not only humans but also many dogs are prone to experiencing coughing symptoms. Differences between daytime and nighttime temperatures, dry weather, and frequent transitions between indoor and outdoor environments can directly affect the bronchial health of dogs, making them more susceptible to respiratory problems. In particular, sudden changes in weather can make a dog's respiratory system sensitive, resulting in noticeable coughing symptoms.
Coughing in…
Cough Care Advance launches Cough Care Advance, an innovative, kid-friendly coug …
Cough Care Advance is introducing an innovative, kid-friendly cough remedy that provides safe, natural, and long-lasting relief.
Parents know how difficult it can be when children are battling a stubborn cough. Whether it's keeping them up at night or disrupting their day at school, finding an effective and gentle solution is a top priority. That's why Cough Care Advance is introducing an innovative, kid-friendly cough remedy that provides safe, natural, and…
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991
This latest report researches the…
Refractory Chronic Cough Therapeutics Market - Pioneering Solutions for Persiste …
Newark, New Castle, USA - new report, titled Refractory Chronic Cough Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Refractory Chronic Cough Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Refractory Chronic Cough Therapeutics market. The report offers…
Cough Systems Market
Global cough systems market size is expected to be worth roughly USD 192.8 million by 2030, growing at a CAGR of more than 8.6% during the projected timeframe of 2022-2030, according to Ameco Research
Cough systems are appliances that assist to cleanse the lungs of excessive cough output by changing the flow patterns, which enhances the airway patency and helps to establish and promote alveolar growth. Excessive coughing produces severe lung…
Global Cough Syrup Market Size, Cough Syrup Market Share, Cough Syrup Market Gro …
The Global "Cough Syrup Market" 2022 research report presents an in-depth analysis of the Cough Syrup Market size, growth, share, segments, manufacturers, and forecast, competition landscape and growth opportunity. The research's goal is to provide market data and strategic insights to help decision-makers to make educated investment decisions while also identifying potential gaps and development possibilities.We also analysed the impact of COVID-19 (Corona Virus) on the product industry chain based…
